Regencell Bioscience Holdings Ltd
regencellbioscience.comWhat Do They Do?
Develops traditional Chinese medicine formulas for attention-deficit/hyperactivity disorder and autism spectrum disorder, with plans to commercialize them for patients.
20-F for FY2026, filed Oct 7, 2026We conduct our business through our wholly-owned subsidiaries, Regencell Bioscience Limited, a company incorporated in Hong Kong on May 12…View ↗
Our goal is to save and improve the lives of ADHD patients, ASD patients, their families and caregivers and become a market leader for the…View ↗
We have completed our first research study with the TCM Practitioner and have standardized TCM formula candidate under development…View ↗
How Do They Make Money?
No revenue reported yet.
20-F for FY2026, filed Oct 7, 2026
How Are They Changing?
Focus narrowed
The older report also described formulas for infectious diseases affecting the immune system; the latest describes the company's focus as attention-deficit/hyperactivity disorder and autism spectrum disorder.
20-F for FY2023, filed Oct 27, 2023 20-F for FY2026, filed Oct 7, 2026We conduct our business through our wholly-owned subsidiaries, Regencell Bioscience Limited, a company incorporated in Hong Kong on May 12…View ↗
We conduct our business through our wholly-owned subsidiaries, Regencell Bioscience Limited, a company incorporated in Hong Kong on May 12…View ↗
Loading...
